DBP International AB: Mexico patent for Temodex / SI-053 is granted
Double Bond Pharmaceutical International AB (publ) ("DBP" or "The Company", org. No. 556991-6082) has today, June 28th 2021, received information about the granting of Mexican patent application concerning the company's front-line product Temodex / SI-053.Patent approval provides protection for the technology and the product in Mexico until at least 2036."This is a very important milestone in the development of SI-053 as Mexico is a fast growing market where we plan to expand the global commercialization of the product," comments Igor Lokot, CEO of DBP. – “We also have other